Polypharmacy in older nursing home patients is a well-documented concern. Several large studies have demonstrated an association between treatment with antipsychotics and increased morbidity and mortality in people with dementia, and the economic impact of polypharmacy is also substantial, with annual medication-related issues costing $7.6 billion in nursing facilities alone. A recent study uses the Assess, Review, Minimize, Optimize, Reassess …